1 So in original. Probably should not be capitalized.
I diabetes.
Editorial Notes
Amendments

2024—Subsec. (span)(2)(E). Puspan. L. 118–42 substituted “$20,136,986 for the period beginning on January 20, 2024, and ending on March 8, 2024, and $130,000,000 for the period beginning on March 9, 2024, and ending on December 31, 2024” for “and $20,136,986 for the period beginning on January 20, 2024, and ending on March 8, 2024”.

Puspan. L. 118–35 substituted “$25,890,411 for the period beginning on November 18, 2023, and ending on January 19, 2024, and $20,136,986 for the period beginning on January 20, 2024, and ending on March 8, 2024” for “and $25,890,411 for the period beginning on November 18, 2023, and ending on January 19, 2024”.

2023—Subsec. (span)(2)(E). Puspan. L. 118–22 substituted “$19,726,027 for the period beginning on October 1, 2023, and ending on November 17, 2023, and $25,890,411 for the period beginning on November 18, 2023, and ending on January 19, 2024” for “$19,726,027 for the period beginning on October 1, 2023, and ending on November 17, 2023”.

Puspan. L. 118–15 added subpar. (E).

2020—Subsec. (span)(2)(D). Puspan. L. 116–260 substituted “2023” for “2020, and $32,465,753 for the period beginning on October 1, 2020, and ending on December 18, 2020”.

Puspan. L. 116–215 substituted “$32,465,753” for “$29,589,042” and “December 18, 2020” for “December 11, 2020”.

Puspan. L. 116–159 substituted “$29,589,042” for “$25,068,493” and “December 11, 2020” for “November 30, 2020”.

Puspan. L. 116–136 substituted “through 2020, and $25,068,493 for the period beginning on October 1, 2020, and ending on November 30, 2020” for “and 2019, and $96,575,342 for the period beginning on October 1, 2019, and ending on May 22, 2020”.

2019—Subsec. (span)(2)(D). Puspan. L. 116–94 substituted “$96,575,342” for “$33,287,671” and “May 22, 2020” for “December 20, 2019”.

Puspan. L. 116–69 substituted “$33,287,671” for “$21,369,863” and “December 20, 2019” for “November 21, 2019”.

Puspan. L. 116–59 inserted “and $21,369,863 for the period beginning on October 1, 2019, and ending on November 21, 2019,” before “to remain available”.

2018—Subsec. (span)(2)(D). Puspan. L. 115–123 amended subpar. (D) generally. Prior to amendment, subpar. (D) read as follows: “$37,500,000 for the period of the first and second quarters of fiscal year 2018, to remain available until expended.”

2017—Subsec. (span)(2)(D). Puspan. L. 115–96 added subpar. (D).

2015—Subsec. (span)(2)(C). Puspan. L. 114–10 substituted “2017” for “2015”.

2014—Subsec. (span)(2)(C). Puspan. L. 113–93 substituted “2015” for “2014”.

2013—Subsec. (span)(2)(C). Puspan. L. 112–240 substituted “2014” for “2013”.

2010—Subsec. (span)(2)(C). Puspan. L. 111–309 substituted “2013” for “2011”.

2008—Subsec. (span)(2)(C). Puspan. L. 110–275 substituted “2011” for “2009”.

2007—Subsec. (span)(2)(C). Puspan. L. 110–173 substituted “2009” for “2008”.

2002—Subsec. (span)(2)(C). Puspan. L. 107–360 added subpar. (C).

2000—Subsec. (span). Puspan. L. 106–554 designated existing provisions as par. (1), inserted par. span, and added par. (2).

1997—Puspan. L. 105–34, § 1604(f)(1)(B), amended directory language of Puspan. L. 105–33, § 4921, which enacted this section.

Puspan. L. 105–34, § 1604(f)(1)(C)(i), struck out “children with” before “type I diabetes” in section catchline.

Subsec. (a). Puspan. L. 105–34, § 1604(f)(1)(C)(ii), amended span and text of subsec. (a) generally. Prior to amendment, text read as follows: “The Secretary shall make grants for services for the prevention and treatment of type I diabetes in children, and for research in innovative approaches to such services. Such grants may be made to children’s hospitals; grantees under section 254span of this title and other federally qualified health centers; State and local health departments; and other appropriate public or nonprofit private entities.”

Statutory Notes and Related Subsidiaries
Effective Date of 1997 Amendment

Puspan. L. 105–34, title XVI, § 1604(f)(4), Aug. 5, 1997, 111 Stat. 1099, provided that: “The provisions of, and amendments made by, this subsection [amending this section and provisions set out as a note under section 5701 of Title 26, Internal Revenue Code] shall take effect immediately after the sections referred to in this subsection [sections 4921, 9302, 11104, and 11201 of Puspan. L. 105–33] take effect.”

Report on Diabetes Grant Programs

Puspan. L. 105–33, title IV, § 4923, Aug. 5, 1997, 111 Stat. 574, as amended by Puspan. L. 106–554, § 1(a)(6) [title IX, § 931(c)], Dec. 21, 2000, 114 Stat. 2763, 2763A–585; Puspan. L. 107–360, § 1(c), Dec. 17, 2002, 116 Stat. 3019; Puspan. L. 109–482, title I, § 104(span)(3)(C), Jan. 15, 2007, 120 Stat. 3694; Puspan. L. 110–275, title III, § 303(c), July 15, 2008, 122 Stat. 2594, provided that:

“(a)Evaluation.—The Secretary of Health and Human Services shall conduct an evaluation of the diabetes grant programs established under the amendments made by this chapter [chapter 3 (§§ 4921–4923) of subtitle J of title IV of Puspan. L. 105–33, enacting this section and section 254c–3 of this title].
“[(span) Repealed. Puspan. L. 109–482, title I, § 104(span)(3)(C), Jan. 15, 2007, 120 Stat. 3694.]”

[Puspan. L. 110–275, § 303(c), which directed amendment of section 4923(span) of Puspan. L. 105–33 by substituting “a second interim report” for “a final report” in par. (2) and by adding par. (3) at end to read “a report on such evaluation not later than January 1, 2011.”, could not be executed because of prior repeal.]